Securities abbreviation: Pony Testing International Group Co.Ltd(300887) securities code: 300887 Pony Testing International Group Co.Ltd(300887)
Pony Testing International Group Co., LTD.
(101, floor 5, building 1, yard 66, Jindai Road, Haidian District, Beijing)
Gem issues shares to specific objects
Feasibility analysis report on the use of raised funds
(Second Revision)
December, 2001
(unless otherwise specified in this report, relevant terms have the same meaning as in the plan for issuing shares to specific objects on the Pony Testing International Group Co.Ltd(300887) gem (Second Revision))
1、 Use plan of the raised funds issued to specific objects
The total amount of funds raised by the company in issuing shares to specific objects this time shall not exceed 1239752500 yuan (including this amount), which shall be used for the following raised investment projects after deducting the issuance expenses:
Unit: 10000 yuan
No. project name total investment amount proposed to be invested in raised funds
1 Pony Testing International Group Co.Ltd(300887) Group Shandong headquarters building and R & D inspection center project 52000.005082.25
2 puni northwest headquarters building (Xi’an) project 46113.0046113.00
3. Supplementary working capital 27000.0027000.00
Total 125113.00123975.25
Before the funds raised in this offering are in place, the company will invest with self raised funds according to the actual situation of the investment projects with raised funds, and replace them after the raised funds are in place. After the raised funds are in place, if the net amount of the actual raised funds after deducting the issuance expenses is less than the total amount of the proposed raised funds, within the scope of the investment projects of the raised funds in this issuance, the company will adjust and finally determine the specific investment projects, sequence and specific investment amount of each project according to the actual amount of the raised funds and the priorities of the projects, The insufficient funds raised shall be raised by the company itself.
2、 Necessity and feasibility analysis of the project invested by the raised funds
(i) Necessity analysis of project construction
1. Serve social development and meet the growing demand for third-party testing
As a third-party high-tech productive science and technology service industry, inspection and testing mainly provides various support for production, consumption and other activities. Its downstream industry involves all aspects of social development and is an indispensable industry for the operation of modern society. On the one hand, inspection and testing can ensure the improvement of quality and efficiency of industrial economy, give play to the role of the bottom line of market access, ensure product quality and safety, and guide green production and consumption; On the other hand, it can promote the upgrading and innovation of Industrial Science and technology, give play to the high-speed role of quality improvement, and encourage the upgrading of production technology. It has the characteristics of strong professionalism, active innovation, high industrial integration and significant driving effect. The report of the 19th National Congress of the Communist Party of China pointed out that at present, China’s economy has changed from a high-speed growth stage to a high-quality development stage. China’s economy is in a key period of transforming the development mode, optimizing the economic structure and transforming the growth power. During the “14th five year plan” period, the long-term demand power of China’s testing market is abundant: first, the development of China’s science and technology and manufacturing industry has entered the stage of technological innovation and quality improvement. Enterprises’ improvement of R & D efficiency and product quality has led to long-term and high-frequency testing demand; Secondly, after the economic development reaches a certain stage, the upgrading of residents’ consumption and the improvement of government regulatory standards promote the continuous improvement of the whole society’s attention to product quality, safety, environmental protection and energy-saving performance, and the type and complexity of detection indicators; Finally, from overseas experience, the downstream of the testing industry is fully diversified, and its demand will continue to increase with the growth of economic activities. Driven by the above driving forces, the market scale of China’s inspection and testing industry will reach 358.592 billion yuan in 2020, with an average annual compound growth rate of 14.50% since 2013. By 2025, the market scale will increase to about 702.6 billion yuan, about twice that of 2020, becoming the most potential high-quality market in the world.
2. Improve the detection technology capability and improve the regional detection network layout
For third-party testing enterprises, laboratory equipment and staffing determine the testing technical ability of the enterprise. There are disadvantages that the service radius of a single laboratory or a single market subject is restricted and the inspection and testing needs of different regions cannot be met at the same time; Large testing institutions can give full play to the synergy among personnel, business and laboratories, with obvious scale effect and stronger growth ability. The company has focused on the inspection and testing industry for nearly 20 years, built four regional headquarters in Beijing, Shanghai, Suzhou and Wuhan, established nearly 30 experimental bases in 22 large and medium-sized cities in China, preliminarily established a service network covering all provinces and cities in China, and formed a certain industry influence in all regions. As the national regional economic development, manufacturing layout and industrial development process have their own characteristics and differences, and the testing market structure and share also have obvious regional characteristics, the proportion of operating revenue of testing institutions in various regions in China in 2020 will be 37.13% in East China, 27.17% in central and South China, 15.96% in North China, 9.80% in Southwest China and 5.75% in Northwest China, 4.19% in Northeast China. The active layout and expansion of laboratory construction and the configuration of relevant equipment platforms in Qingdao and Xi’an will greatly expand and enhance the company’s ability to meet customer needs in North China, East China and Northwest China, improve the company’s technical service efficiency and provide great impetus for the company’s sustainable development.
3. Expand inspection and testing business in emerging areas and extend to high value-added business areas
After listing, while continuously consolidating the competitive advantage in traditional fields, the company closely follows the development trend of the industry and, on the basis of consolidating the original business, Actively tap the potential of biomedical R & D services (CRO / cdmo), electronic products, environmental reliability experiments, medical device testing, high-end equipment, new energy vehicles, carbon peak / carbon neutralization, cosmetics and other subdivided fields: in biomedical R & D services In the field of (CRO / cdmo), the company’s business covers drug discovery, drug synthesis, drug preparation, drug analysis, safety and effectiveness research, drug analysis, etc.; in the field of medical inspection, it covers antibody detection, precision medicine, tumor screening, gene detection, environmental and food pathogen detection, etc.; in the field of medical device inspection, it covers all kinds of active medical devices and passive medical devices Mechanical inspection, EMC test, safety inspection, performance test, etc; Cosmetics testing covers risk substance testing, human efficacy evaluation, toxicology experiment, product type inspection and human efficacy experiment of cosmetics; New energy vehicle testing covers the whole vehicle, parts, interior and exterior trim, including ELV testing, reliability testing, electromagnetic compatibility, VOC testing and other testing items; In addition, the company has made rapid development in energy conservation and environmental protection / carbon trading / carbon neutralization / carbon verification, battery testing, lithium battery safety testing, electronic and electrical, electrical equipment, environment and reliability testing, EMC testing, software evaluation / network security and other fields. With the implementation of this raised investment project, the company’s competitive strength in the above emerging fields will be further enhanced and its profitability will be further improved.
4. Strategically strengthen cro / cdmo business and build a one-stop R & D service platform
With the rapid improvement of the R & D strength and internal management level of China Meheco Group Co.Ltd(600056) cro / cdmo enterprises, China is gradually becoming the first choice for the R & D transfer of international pharmaceutical enterprises. In the future, benefiting from the general trend of international transfer of pharmaceutical R & D and the opportunity of the rise of China’s innovative drugs, China’s cro / cdmo industry will continue to maintain a high-speed growth trend on the existing basis. In addition, China’s cro / cdmo industry will show an integrated development trend, that is, the services provided by cro / cdmo enterprises will cover multiple links from drug discovery, drug synthesis, dosage form research, drug analysis, drug preclinical research, CMO production and technical achievement transformation, run through all stages of new drug research and development, and provide customers with “one-stop” solutions. Relying on the cooperative relationship and years of professional accumulation established by the company with many well-known pharmaceutical enterprises at home and abroad, as well as national, provincial and municipal scientific research institutes and universities, the company has a number of advanced professional laboratories and relevant talent reserves such as drug synthesis, dosage form research, drug analysis, pharmacology and toxicology. The cro / cdmo business launched by the company this time is conducive to making full use of the accumulated customer resources and technical experience, expanding the company’s service scope, exerting synergy with the original testing business, realizing one-stop service for customers and increasing customer stickiness.
5. Comply with the development trend of the industry and build a world-class comprehensive inspection and Certification Group
The inspection and testing industry serves manufacturers and traders in many industries, and its industry periodicity is related to the economic cycle and prosperity of each industry. Therefore, the inspection and testing institutions with centralized service industry and single service field are vulnerable to the economic cycle fluctuations of relevant industries, while the comprehensive inspection and testing institutions with more cross industries and service fields have strong risk dispersion ability, relatively less affected by the economic cycle of a single industry and strong ability to resist risks. China’s inspection and testing high-quality development and the 14th five year plan conference stressed the need to strive to basically establish an inspection and testing system to meet the needs of high-quality development by 2025, emerge a number of inspection and testing groups with large scale, high level, good reputation and wide service, and form a number of characteristic areas with centralized and continuous development of inspection and testing high-tech service industry, Cultivate a number of well-known inspection and testing brands with international influence. Under this background, the leading enterprises in the third-party testing industry began to develop into comprehensive third-party testing enterprises through self construction, M & A and other forms. Comprehensiveness and scale are the development trend of the testing and testing industry in the future. Although the company has grown into one of the large-scale comprehensive private testing institutions in China, it has cooperated with SGS in Switzerland, BV in France Compared with international certification bodies such as Eurofins and Intertek group, the company still has great room for improvement in testing scale, testing field and market share. In order to achieve the strategic goal of becoming a world-class comprehensive inspection and Certification Group, the company urgently needs to expand the testing business market, actively improve the market influence and further enhance the company’s core competitiveness.
（2） Feasibility analysis of project construction
1. The implementation of the project conforms to the national industrial policy guidance
In recent years, the state has successively issued a series of industry support policies, and the favorable policy environment provides a basic guarantee for the construction of the company’s investment projects with raised funds. The State Council’s several opinions on accelerating the development of science and technology service industry (GF [2014] No. 49) requires that we focus on the development of professional science and technology services such as inspection, testing and certification and comprehensive science and technology services, so as to improve the support capacity of science and technology service industry for scientific and technological innovation and industrial development. The 13th five year plan for the development of certification, accreditation, testing and testing (AQSIQ [2016] issued by AQSIQ) No. 524) clearly accelerate the industrialization development of inspection, testing and certification, support the integration of inspection, testing and certification institutions, and support the development of “one-stop” services and “integrated” solutions for inspection, testing and certification. In 2017, the state listed “inspection and testing services”, “commissioned contract research (CRO) of preclinical research and clinical trials aimed at obtaining marketing license” and “commissioned contract production (CMO) of raw materials, excipients and preparations of different scales” in the guidance catalogue of key products and services of strategic emerging industries. In 2018, the State Council The opinions on strengthening the construction of quality certification system and promoting total quality management (GF [2018] No. 3) encourages and supports social forces to carry out inspection, testing and certification business, strengthen the government’s purchase of services, and create a market environment for fair competition among various subjects. The national development and Reform Commission issued the notice on organizing the implementation of the special project for the construction of biomedical contract R & D and production service platform (fgbgj [2018] No. 633) proposed to focus on supporting the construction of a number of high-level and international comprehensive biomedical contract R & D and production service platforms. In 2019, the drug administration law (Revised Draft) was fully implemented by drug marketing license holders (MAH) system has fully stimulated the R & D vitality of cro / cdmo enterprises and become a strong support for the rapid development of the industry. The 2020 government work report clearly pointed out the need to “develop productive service industries such as R & D and design, modern logistics, inspection, testing and certification”.
2. The company has accumulated good reputation and industry experience, and its scale advantage is beginning to show
Founded in 2002, the company is one of the earliest established third-party inspection and testing institutions in China. After nearly 20 years of development and accumulation, the company has been widely recognized by government regulatory authorities and customers abroad with strong technical strength and professional service ability. The company has been participating in local market supervision and management, agriculture, rural areas The supervision, sampling inspection and risk monitoring of ecological environment and other departments have provided detection technical support for food safety, environmental protection and product quality supervision for a long time, and have established close cooperative relations with many enterprises in food, environment, biomedicine, electronics, toys, textiles, daily chemicals and other industries. Since its establishment, the company has been undertaking high-specification and large-scale important and urgent testing support tasks in a number of major activities and events at home and abroad, and has participated in the drafting, preparation and revision of international standards, national standards and industrial standards for many times, contributing to the improvement of the overall technical level of China’s testing industry. Since 2016, the company has gradually arranged the whole chain service of bio pharmaceutical cro / cdmo, maintained good cooperative relations with many provincial and municipal drug inspection institutes and many well-known pharmaceutical enterprises at home and abroad, such as Bayer, Beijing Tongrentang Co.Ltd(600085) , Tasly Pharmaceutical Group Co.Ltd(600535) , Sinopharm group, Dong-E-E-Jiao Co.Ltd(000423) , Qilu pharmaceutical, etc., and established high brand awareness and social credibility in the industry.
3. The company has strong R & D capability and technology accumulation
Since its establishment, the company has obtained the national high-tech enterprise qualification, has a solid technical foundation and scientific research tradition, adheres to the technical development road of “independent research and development and continuous innovation”, and has mastered more mature detection methods and technologies after nearly 20 years of development. Up to now, the group has participated in the formulation and revision of 57 national and industrial standards, and undertaken a number of national R & D projects. Following the group’s headquarters in November 2019
